Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caudal-type homeobox protein 1 (CDX1) is a DNA-binding transcription factor encoded by the CDX1 gene and classified as a homeobox protein. It is primarily expressed in the developing endoderm and is critical for regulating intestine-specific gene expression, driving enterocyte differentiation, and maintaining epithelial identity throughout adulthood. CDX1 integrates diverse signaling pathways, including Wnt/β-catenin and retinoid signaling, to promote intestinal differentiation and homeostasis. It plays important roles both in embryonic development (notably in cardiovascular formation via epithelial-to-mesenchymal transition) and in adult tissue, functioning as a tumor suppressor in colorectal cancer by driving epithelial differentiation and limiting cell proliferation. Dysregulation of CDX1 can contribute to metaplastic and neoplastic conversion, and although it is not considered a classic drug target like a receptor or enzyme, it is frequently studied in the context of cancer biology and epithelial disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caudal-type homeobox protein 1 (CDX1).